Stefania Cazzato, Head of Strategy and Operations for the Europe and Canada Oncology Business Unit at Takeda, shared on LinkedIn:
“I’m excited to share that I recently started a new role as Head of Strategy and Operations for the Europe and Canada Oncology Business Unit at Takeda.
I’m looking forward to partnering with colleagues across EUCAN Oncology to shape our strategy, strengthen how we work, and support our shared ambition to make a meaningful difference for people living with cancer.
I’d like to thank Annarita Egidi for her trust and support as I take on this new role. I’m looking forward to partnering with her and the EUCAN Oncology team in this next chapter.
I’m also grateful to Liz Lewis and Laura Walton for their leadership, guidance, and support during my time as Global Access Lead. I’m proud of what we accomplished together and thankful for the collaboration and trust.
I’m excited for this next chapter and what we’ll achieve together.”
About Takeda
Takeda Oncology is the global oncology business unit of Takeda Pharmaceutical Company Limited, focused on developing innovative cancer treatments across thoracic, gastrointestinal and hematologic cancers. Building on decades of oncology expertise, the organization advances research and development through scientific innovation and strategic partnerships, with a commitment to addressing unmet patient needs and improving access to cancer medicines worldwide.